Revvity, Inc. — Company profile
Healthcare · Diagnostics & Research · United States
Last price 165.78 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 18.50B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptors and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Details
| Name | Revvity, Inc. |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 11000 |
| Founded | 1937 |
| Ceo | Prahlad Singh |
| Country | United States |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US7140461093 |
| Cusip | 714046109 |
| Cik | 31791 |
| Sic | 3826 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Prahlad R. Singh Ph.D. | Chief Executive Officer, President and Director |
| Maxwell Krakowiak | Senior Vice President and Chief Financial Officer |
| Tajinder S. Vohra | Senior Vice President of Global Operations |
| Joel S. Goldberg | Senior Vice President of Administration, General Counsel and Secretary |
| Miriame Victor | Senior Vice President and Chief Business Officer |
| Anita Gonzales | Chief Accounting Officer, Vice President and Controller |
| Bryan A. Kipp | Senior Vice President of Technology and Licensing |
| Dr. Madhuri Hegde FACMG, Ph.D. | Senior Vice President and Chief Scientific Officer |
| Stephen Barr Willoughby | Senior Vice President of Investor Relations and Head of ESG |
| Magali Four | Senior Vice President and Chief People and Culture Officer |
Contact
| Address | 77 4th Avenue, Waltham, Massachusetts 02451, United States |
| Phone | 781 663 6900 |
| Website | https://www.revvity.com |